In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

The in vitro activities of delafloxacin and comparator antimicrobial agents against 6,485 bacterial isolates collected from medical centers in Europe and the United States in 2014 were tested. Delafloxacin was the most potent agent tested against methicillin-susceptible Staphylococcus aureus (MSSA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaller, M. A., Sader, H. S., Rhomberg, P. R., Flamm, R. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365668/
https://www.ncbi.nlm.nih.gov/pubmed/28167542
http://dx.doi.org/10.1128/AAC.02609-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365668/
https://www.ncbi.nlm.nih.gov/pubmed/28167542
http://dx.doi.org/10.1128/AAC.02609-16

Ejemplares similares